Agilent to Expand Portfolio and Capabilities in Cell Analysis with Acquisition of ACEA Biosciences

SANTA CLARA, Calif. Highlights: Acquisition adds a differentiated portfolio and organizational capabilities in the fast-growing cell analysis market Combined portfolio expands cell-based applications and workflows allowing customers more choices to answer more questions from a single sample Combined clinical reagent and instrument portfolio allows for optimized complete solutions Expands R&D, Manufacturing & Operations, and Commercial